Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...
GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...
BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.
TeamLogic IT, a national provider of managed IT services and technology support for small and midsize businesses, recently celebrated the franchise ...
BPM31510IV is also a lead candidate to treat solid tumours such as glioblastoma multiforme and pancreatic cancer.
BPGbio received an FDA Rare Pediatric Disease Designation for its potential treatment for primary coenzyme Q10 deficiency.